医学
呼出气一氧化氮
哮喘
生物标志物
嗜酸性
病态的
重症监护医学
哮喘的病理生理学
临床意义
哮喘管理
病理生理学
免疫学
内科学
病理
化学
支气管收缩
生物化学
作者
Fabio Luigi Massimo Ricciardolo,Valentina Sorbello,Giorgio Ciprandi
出处
期刊:Allergologia et immunopathologia
[Codon Publications]
日期:2015-11-01
卷期号:43 (6): 609-616
被引量:20
标识
DOI:10.1016/j.aller.2014.11.004
摘要
The present review is focused on literature concerning the relevance of fractional exhaled nitric oxide (FeNO) in clinical practice from a pathophysiological point of view. There is increasing evidence that asthma is a heterogeneous pathological condition characterised by different phenotypes/endotypes related to specific biomarkers, including FeNO, helpful to predict therapeutic response in selected asthmatic populations. Nowadays FeNO, a non-invasive biomarker, appears to be useful to foresee asthma developing, to recognise specific asthma phenotypes, like the eosinophilic, to ameliorate asthma diagnosis and management in selected populations and to predict standard corticosteroid and biologic therapy efficacy. In addition, FeNO assessment may also be useful in patients with allergic rhinitis in order to detect the potential involvement of eosinophilic bronchial inflammation in “case finding” subjects at risk of asthma diagnosis. Therefore, it is possible to hypothesise a future with an appropriate use of FeNO by physicians dealing with worrisome clinical issues in specific asthma phenotypes.
科研通智能强力驱动
Strongly Powered by AbleSci AI